462 In six randomized trials (2916 patients) over a mean follow-up of
60 months, the occurrence of restenosis greater than
70%/occlusion in patients undergoing CAS or PTA was
10.3% (95% CI, 6.0-16.4). In Ô¨Åve trials (2,716 patients) and
over a mean follow-up of 62 months restenosis risk
greater